Cipla expects surge in demand for respiratory drugs, inhalers in winter
Cipla, the market leader in respiratory therapies, expects a surge in demand for respiratory drugs and inhalers
Read moreCipla, the market leader in respiratory therapies, expects a surge in demand for respiratory drugs and inhalers
Read more